• LAST PRICE
    28.4200
  • TODAY'S CHANGE (%)
    Trending Up0.4900 (1.7544%)
  • Bid / Lots
    28.4000/ 1
  • Ask / Lots
    28.5000/ 5
  • Open / Previous Close
    28.1700 / 27.9300
  • Day Range
    Low 27.2600
    High 28.6800
  • 52 Week Range
    Low 16.7500
    High 36.0800
  • Volume
    198,670
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 27.93
TimeVolumeAGIO
09:32 ET189428.43
09:35 ET96627.8
09:37 ET170027.615
09:42 ET210027.27
09:44 ET10027.26
09:46 ET80027.43
09:48 ET60027.53
09:50 ET50027.61
09:51 ET531727.605
09:53 ET580027.58
09:55 ET31927.54
09:57 ET368427.55
10:00 ET313527.725
10:02 ET453227.63
10:04 ET37427.53
10:06 ET40027.65
10:08 ET57127.85
10:09 ET119827.855
10:11 ET453827.92
10:13 ET20028.05
10:18 ET537428.145
10:20 ET40028.07
10:22 ET515428.3
10:26 ET30028.29
10:27 ET189228.19
10:29 ET13228.21
10:33 ET50028.175
10:36 ET30028.29
10:38 ET40028.33
10:42 ET20028.34
10:44 ET60028.22
10:45 ET20028.11
10:47 ET10028.14
10:51 ET10028.075
10:54 ET10028.02
10:56 ET60028.12
10:58 ET10028.15
11:02 ET10028.23
11:03 ET342828.22
11:05 ET40028.24
11:07 ET70028.14
11:09 ET60027.985
11:12 ET172927.98
11:14 ET40027.98
11:16 ET10027.94
11:20 ET139728
11:21 ET10027.96
11:23 ET10028
11:25 ET489828.06
11:27 ET10028.02
11:30 ET94428.13
11:32 ET20028.12
11:34 ET40028.115
11:38 ET190628.14
11:39 ET429128.21
11:41 ET90028.12
11:43 ET10028.11
11:45 ET30028.115
11:48 ET10028.07
11:50 ET10028.11
11:56 ET80028.08
11:57 ET10028.05
12:01 ET60028.03
12:03 ET20028.06
12:06 ET20028.07
12:08 ET50027.98
12:12 ET50028.04
12:21 ET130028
12:26 ET40027.97
12:30 ET10027.99
12:32 ET30027.92
12:33 ET83827.88
12:39 ET10027.92
12:42 ET50027.93
12:46 ET10027.945
12:48 ET30028.01
12:50 ET10028.035
12:51 ET10028.11
12:53 ET10028.13
12:55 ET10028.14
12:57 ET10028.19
01:00 ET20028.19
01:02 ET10028.19
01:04 ET10028.19
01:06 ET50028.22
01:08 ET150028.18
01:09 ET60028.15
01:11 ET274628.15
01:13 ET30628.15
01:15 ET90028.14
01:18 ET140028.17
01:20 ET140028.21
01:22 ET131028.33
01:27 ET30028.38
01:36 ET72128.48
01:38 ET30028.5
01:40 ET140028.45
01:42 ET173228.47
01:44 ET20028.46
01:45 ET441828.655
01:47 ET10028.6
01:49 ET65228.63
01:51 ET20028.6
01:54 ET92528.58
01:56 ET80028.53
01:58 ET30028.5
02:02 ET30028.39
02:03 ET40028.36
02:05 ET10028.29
02:12 ET62428.255
02:18 ET30028.29
02:20 ET60028.28
02:23 ET20028.35
02:30 ET134028.295
02:32 ET90028.27
02:36 ET10028.175
02:38 ET20028.18
02:41 ET20028.27
02:45 ET20028.2
02:48 ET30028.24
02:52 ET60128.23
02:54 ET50028.27
02:56 ET30028.28
02:57 ET23228.285
02:59 ET86828.25
03:01 ET40028.21
03:03 ET10028.21
03:06 ET10028.25
03:08 ET161028.3
03:10 ET60028.27
03:12 ET10028.27
03:14 ET20028.27
03:15 ET80028.26
03:17 ET70028.3
03:19 ET204028.29
03:26 ET80028.405
03:28 ET75228.42
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesAGIO
Agios Pharmaceuticals Inc
1.5B
-4.2x
---
United StatesSAVA
Cassava Sciences Inc
1.5B
-21.4x
---
United StatesEQRX
EQRx Inc
1.6B
-9.9x
---
United StatesRYTM
Rhythm Pharmaceuticals Inc
1.5B
-7.5x
---
United StatesSWTX
SpringWorks Therapeutics Inc
1.5B
-4.7x
---
United StatesDICE
Dice Therapeutics Inc
1.6B
-15.9x
---
As of 2022-12-08

Company Information

Agios Pharmaceuticals, Inc. is a biopharmaceutical company. The Company's lead product candidate in its genetically defined disease (GDD) portfolio, PYRUKYND (Mitapivat), is an activator of both wild-type and a variety of mutant pyruvate kinase (PK) enzymes, for the treatment of hemolytic anemias. The Mitapivat is an orally available small molecule and a potent activator of the pyruvate kinase R (PKR) enzymes. In addition, it is also evaluating mitapivat for the treatment of a- and b-thalassemia and sickle cell disease (SCD) in ongoing clinical trials. The Company is also developing AG-946, a clinical-stage oral activator of PKR enzymes for the treatment of hemolytic anemias and other indications, including SCD and anemia associated with low-to intermediate-risk myelodysplastic syndrome (L-IR MDS), which is in Phase I clinical study.

Contact Information

Headquarters
88 Sidney StreetCAMBRIDGE, MA, United States 02139
Phone
617-649-8600
Fax
302-655-5049

Executives

Chairman of the Board
Jacqualyn Fouse
Chief Executive Officer, Director
Brian Goff
Chief Financial Officer
Cecilia Jones
Principal Accounting Officer
T. J. Washburn
Chief Legal Officer
James Burns

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.5B
Revenue (TTM)
$9.9M
Shares Outstanding
54.9M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.02
EPS
$-6.72
Book Value
$23.78
P/E Ratio
-4.2x
Price/Sales (TTM)
154.5
Price/Cash Flow (TTM)
---
Operating Margin
-3,849.02%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.